1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 18th March 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

The use of monitoring devices such as actometers to measure outcomes in clinical trials. Discussion thread

Discussion in 'ME/CFS research' started by Sly Saint, Sep 18, 2018.

  1. ladycatlover

    ladycatlover Senior Member (Voting Rights)

    Messages:
    3,702
    Location:
    Liverpool, UK
    Pah! Yet another variable! :yawn: Also discriminates against those poor plebs (like me :thumbsup:) who don't have expensive iPhones :thumbsdown: but have to rely on Android. :android: I would think that it's much easier to use an ap to record stuff than faff around with charts. :arghh: :eek: :rolleyes:
     
    Inara, MEMarge and Invisible Woman like this.
  2. ladycatlover

    ladycatlover Senior Member (Voting Rights)

    Messages:
    3,702
    Location:
    Liverpool, UK
    MeSci, NelliePledge, MEMarge and 3 others like this.
  3. Arnie Pye

    Arnie Pye Senior Member (Voting Rights)

    Messages:
    6,047
    Location:
    UK
    I found the BBC article : https://www.bbc.co.uk/news/technology-45590293

    It's a bit later than planned but 1984 is probably 95% here already.

    Edit : Thanks for the heads up on this, IW.
     
  4. chrisb

    chrisb Senior Member (Voting Rights)

    Messages:
    4,602
    "But it said the data it had collected so far suggested that Vitality policyholders lived between 13 and 21 years longer than the rest of the insured population."

    One wonders whether that is a subjective measurement.

    Sorry, that's an old joke.
     
    Woolie, MEMarge, ladycatlover and 3 others like this.

Share This Page